Paris, France

Ivo Glynne Gut

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Roche Molecular Systems, Inc., Cea/institut De Genomique—centre National De Genotypage, Commissariat a L'energie Atomique Et Aux Energies Alternatives. Active years: 2011-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ivo Glynne Gut. Retrieved from https://idiyas.com/inventor/ivo-glynne-gut

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 33.3

 

 

Average Co-Inventor Count = 3.4

ph-index = 1


Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ivo Glynne Gut: Innovator in Nucleic Acid Detection and HLA Typing

Introduction

Ivo Glynne Gut is a prominent inventor based in Paris, France. He has made significant contributions to the field of molecular biology, particularly in nucleic acid detection and HLA typing. With a total of three patents to his name, Gut's work has advanced the methodologies used in genetic analysis.

Latest Patents

One of Gut's latest patents is focused on ribonucleotide tag nucleic acid detection. This application provides polynucleotides that include 5'-tails with sequence segments useful for detecting target nucleic acid sequences. The polynucleotides amplify a subsequence of a target nucleic acid in the presence of ribonucleotides, which are incorporated into amplification products. The resulting fragments can indicate the presence or absence of target nucleic acids. Another significant patent is a method for HLA typing, which identifies DNA sequence elements in complex sequences. This method allows for the differentiation of mini-haplotypes on different alleles through enzymatic primer extension reactions and mass spectrometry analysis. It is particularly useful for DNA-based HLA typing and offers advantages over conventional methods.

Career Highlights

Throughout his career, Ivo Glynne Gut has worked with notable companies such as Roche Molecular Systems, Inc. and CEA/Institut de Genomique—Centre National de Genotypage. His experience in these organizations has contributed to his expertise in molecular diagnostics and genetic research.

Collaborations

Gut has collaborated with esteemed colleagues, including David H. Gelfand and Keith Bauer. These partnerships have further enriched his research and development efforts in the field of genetics.

Conclusion

Ivo Glynne Gut's innovative work in nucleic acid detection and HLA typing has made a lasting impact on molecular biology. His patents reflect a commitment to advancing genetic analysis techniques, showcasing his role as a leading inventor in this vital area of research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…